Dhaka, Nov. 6 -- An experimental gene therapy infused directly into the human brain has reduced monthly seizures by more than 90 percent in patients with drug-resistant epilepsy, reports The Independent.

The clinical trial, published in The New England Journal of Medicine, involved three adult participants with severe, treatment-resistant epilepsy caused by hippocampal sclerosis.

Surgeons delivered an engineered virus into damaged brain tissue, enabling target neurons to bind with an existing oral medication that dials down excessive electrical activity.

Following treatment, monthly seizures fell from 4.5 to 0.5 for two participants, while the third experienced a complete drop from four to zero.

Unlike traditional surgical options tha...